These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27070647)

  • 1. Neuromodulation and female pelvic disorders.
    Noblett K
    Curr Opin Urol; 2016 Jul; 26(4):321-7. PubMed ID: 27070647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for explantation due to infection after sacral neuromodulation: a multicenter retrospective case-control study.
    Myer ENB; Petrikovets A; Slocum PD; Lee TG; Carter-Brooks CM; Noor N; Carlos DM; Wu E; Van Eck K; Fashokun TB; Yurteri-Kaplan L; Chen CCG
    Am J Obstet Gynecol; 2018 Jul; 219(1):78.e1-78.e9. PubMed ID: 29630890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
    Girtner F; Burger M; Mayr R
    Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Is New in Neuromodulation?
    Moore CK; Rueb JJ; Derisavifard S
    Curr Urol Rep; 2019 Aug; 20(9):55. PubMed ID: 31388779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
    Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
    Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacral Nerve Stimulation as a Therapy for Patients With Refractory Voiding and Bowel Dysfunction.
    Noblett KL; Buono K
    Obstet Gynecol; 2018 Dec; 132(6):1337-1345. PubMed ID: 30399090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique.
    Adelstein SA; Lee W; Gioia K; Moskowitz D; Stamnes K; Lucioni A; Kobashi KC; Lee UJ
    Neurourol Urodyn; 2019 Aug; 38(6):1595-1601. PubMed ID: 31044466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of sacral neuromodulation in modern urogynaecology practice: a review of recent literature.
    Tahseen S
    Int Urogynecol J; 2018 Aug; 29(8):1081-1091. PubMed ID: 29302716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sacral nerve stimulation for the treatment of refractory voiding and bowel dysfunction.
    Noblett KL; Cadish LA
    Am J Obstet Gynecol; 2014 Feb; 210(2):99-106. PubMed ID: 23899452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
    Hoda MR; Fornara P
    Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pulse rate changes on the clinical outcome of sacral neuromodulation.
    Marcelissen TA; Leong RK; Nieman FH; de Bie RA; van Kerrebroeck PE; de Wachter SG
    J Urol; 2011 May; 185(5):1781-5. PubMed ID: 21420118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of sacral neuromodulation on pudendal nerve function and female sexual function.
    Parnell BA; Howard JF; Geller EJ
    Neurourol Urodyn; 2015 Jun; 34(5):456-60. PubMed ID: 24615871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation?
    Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; van Kerrebroeck P
    J Urol; 2018 Jun; 199(6):1584-1590. PubMed ID: 29291416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromodulation in urology, state of the art.
    Ammirati E; Giammò A; Manassero A; Carone R
    Urologia; 2019 Nov; 86(4):177-182. PubMed ID: 31368415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of sacral neuromodulation with the tined lead procedure.
    Marcelissen TA; Leong RK; de Bie RA; van Kerrebroeck PE; de Wachter SG
    J Urol; 2010 Nov; 184(5):1997-2000. PubMed ID: 20850820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sacral neuromodulation in urological indications: the Finnish experience.
    Vaarala MH; Tammela TL; Perttilä I; Luukkonen P; Hellström P
    Scand J Urol Nephrol; 2011 Feb; 45(1):46-51. PubMed ID: 20961268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non-obstructive urinary retention: >10 years of clinical experience.
    Chartier-Kastler E
    BJU Int; 2008 Feb; 101(4):417-23. PubMed ID: 18070181
    [No Abstract]   [Full Text] [Related]  

  • 18. Sacral Neuromodulation: Determining Predictors of Success.
    Morgan TN; Pace N; Mohapatra A; Ren D; Kunkel G; Tennyson L; Shepherd JP; Chermansky CJ
    Urology; 2021 Jul; 153():124-128. PubMed ID: 32619594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving clinical outcomes for women with overactive bladder or urinary retention symptoms: a comparison of motor response voltages (1-9 V) during Stage 1 sacral neuromodulation.
    Marinkovic SP; Ford JC
    BJU Int; 2018 Sep; 122(3):472-479. PubMed ID: 29637712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacral Nerve Stimulation for Pediatric Lower Urinary Tract Dysfunction: Development of a Standardized Pathway with Objective Urodynamic Outcomes.
    Schober MS; Sulkowski JP; Lu PL; Minneci PC; Deans KJ; Teich S; Alpert SA
    J Urol; 2015 Dec; 194(6):1721-6. PubMed ID: 26141849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.